Mesenchymal stem cells: Biological characteristics and potential clinical applications

Cloning and Stem Cells

Volumn 6, Issue 4, 2004, Pages 369-374

  Kassem, Moustapha ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL TRAIT; CARTILAGE CELL; CELL DIFFERENTIATION; CELL LINEAGE; CELL TYPE; CLONOGENESIS; CONFERENCE PAPER; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; GENE THERAPY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOLOGICAL TOLERANCE; MESENCHYME CELL; MESODERM; NERVE CELL; OSTEOBLAST; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; STEM CELL; STEM CELL TRANSPLANTATION; SYSTEMIC DISEASE; TISSUE ENGINEERING; TISSUE INJURY;

EID: 11144252801     PISSN: 15362302     EISSN: None     Source Type: Journal    
DOI: 10.1089/clo.2004.6.369     Document Type: Conference Paper

References (47)

1. Allay, J.A., Dennis, J.E., Haynesworth, S.E., et al. (1997). LacZ and interleukin-3 expression in vivo after retroviral transduction of marrow-derived human osteogenic mesenchymal progenitors. Hum. Gene Ther. 8, 1417-1427.
2. Assmus, B., Schachinger, V., Teupe, C., et al. (2002). Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction - (TOPCARE-AMI). Circulation 106, 3009-3017.
3. Badiavas, E.V., and Falanga, V. (2003). Treatment of chronic wounds with bone marrow-derived cells. Arch. Dermatol. 139, 510-516.
4. Bianco, P., and Robey, P.G. (2001). Stem cells in tissue engineering. Nature 414, 118-121.
5. Bruder, S.P., Fink, D.J., and Caplan, A.I. (1994). Mesenchymal stem cells in bone development, bone repair, and skeletal regeneration therapy. J. Cell Biochem. 56, 283-294.
6. Campisi, J. (2001). From cells to organisms: can we learn about aging from cells in culture? Exp. Gerontol. 36, 607-618.
7. D'ippolito, G., Diabira S, Howard, G.A., et al. (2004). Marrow-isolated adult multilineage inducible (MIAMI) cells, a unique population of postnatal young and old human cells with extensive expansion and differentiation potential. J. Cell Sci. 117, 2971-2981.
8. De Bari, C., Dell'Accio, F., Tylzanowski, P., et al. (2001). Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum. 44, 1928-1942.
9. Diduch, D.R., Jordan, L.C., Mierisch, C.M., et al. (2000). Marrow stromal cells embedded in alginate for repair of osteochondral defects. Arthroscopy 16, 571-577.
10. Fouillard, L., Bensidhoum, M., Bories, D., et al. (2003). Engraftment of allogeneic mesenchymal stem cells in the bone marrow of a patient with severe idiopathic aplastic anemia improves stroma. Leukemia 17, 474-476.
11. Friedenstein, A.J. (1980). Stromal mechanisms of bone marrow: cloning in vitro and retransplantation in vivo. Hamatol. Bluttransfusion 25, 19-29.
12. Friedenstein, A.J. (1991). Osteogenic stem cells in the bone marrow. Bone Miner. 7, 243-272.
13. Gao, J., Dennis, J.E., Muzic, R.F., et al. (2001). The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. Cells Tissues Organs 169, 12-20.
14. Gronthos, S., Graves, S.E., Ohta, S., et al. (1994). The STRO-1+ fraction of adult human bone marrow contains the osteogenic precursors. Blood 84, 4164-4173.
15. Horwitz, E.M., Gordon, P.L., Koo, W.K.K., et al. (2002). Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc. Nat. Acad. Sci. USA 99, 8932-8937.
16. Horwitz, E.M., Prockop, D.J., Fitzpatrick, L.A., et al. (1999). Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat. Med. 5, 309-313.
17. Jiang, Y., Jahagirdar, B.N., Reinhardt, R.L., et al. (2002). Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418, 41-49.
18. Johnstone, B., Hering, T.M., Caplan, A.I., et al. (1998). In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp. Cell Res. 238, 265-272.
19. Justesen, J., Stenderup, K., Eriksen, E.F., et al. (2002). Maintenance of osteoblastic and adipocytic differentiation potential with age and osteoporosis in human marrow stromal cell cultures. Calcif. Tissue Int. 71, 36-44.
20. Kassem, M., Ankersen, L., Eriksen, E.F., et al. (1997). Demonstration of cellular aging and senescence in serially passaged long-term cultures of human trabecular osteoblasts. Osteoporosis Int. 7, 514-524.
21. Kassem, M., Mosekilde, L., and Eriksen, E.F. (1993). 1,25- dihydroxyvitamin D3 potentiates fluoride-stimulated collagen type I production in cultures of human bone marrow stromal osteoblast-like cells. J. Bone Min. Res. 8, 1453-1458.
22. Koc, O.N., Day, J., Nieder, M., et al. (2002). Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH). Bone Marrow Transplant. 30, 215-222.
23. Koc, O.N., Gerson, S.L., Cooper, B.W., et al. (2000). Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J. Clin. Oncol. 18, 307-316.
24. Kon, E., Muraglia, A., Corsi, A., et al. (2000). Autologous bone marrow stromal cells loaded onto porous hydroxyapatite ceramic accelerate bone repair in critical-size defects of sheep long bones. J. Biomed. Mater. Res. 49, 328-337.
25. Krebsbach, P.H., Kuznetsov, S.A., Satomura, K., et al. (1997). Bone formation in vivo: comparison of osteogenesis by transplanted mouse and human marrow stromal fibroblasts. Transplantation 63, 1059-1069.
26. Kuznetsov, S.A., Mankani, M.H., Gronthos, S., et al. (2001). Circulating skeletal stem cells. J. Cell Biol. 153, 1133-1140.
27. Le Blanc, K., Gotherstrom, C., Tammik, C., et al. (2003). HLA expression and immunologic properties of differentiated and undifferentiated adult and fetal mesenchymal stem cells. Bone Marrow Transplant. 31, S244-S245.
28. Lodie, T.A., Blickarz, C.E., Devarakonda, T.J., et al. (2002). Systematic analysis of reportedly distinct populations of multipotent bone marrow-derived stem cells reveals a lack of distinction. Tissue Eng. 8, 739-751.
29. Luria, E.A., Panasyuk, A.F., and Friedenstein, A.Y. (1971). Fibroblast colony formation from monolayer cultures of blood cells. Transfusion. 11, 345-349.
30. Miura, M., Gronthos, S., Zhao, M., et al. (2003). SHED: Stem cells from human exfoliated deciduous teeth. Proc. Natl. Acad. Sci. USA 100, 5807-5812.
31. Ohgushi, H., Goldberg, V.M., and Caplan, A.I. (1989). Repair of bone defects with marrow cells and porous ceramic. Experiments in rats. Acta Orthop. Scand. 60, 334-339.
32. Pittenger, M.F., Mackay, A.M., Beck, S.C., et al. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284, 143-147.
33. Quarto, R., Mastrogiacomo, M., Cancedda, R., et al. (2001). Repair of large bone defects with the use of autologous bone marrow stromal cells. N. Engl. J. Med. 344, 385-386.
34. Rattan, S.I.S. (2003). Aging outside the body: usefulneess of the Hayflick system. In Aging of Cells In and Outside the Body. S.C. Kaul, et al., eds. (Kuwer Academic, London), pp. 1-8.
35. Reyes, M., Lund, T., Lenvik, T., et al. (2001). Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood 98, 2615-2625.
36. Rickard, D.J., Kassem, M., Hefferan, T.E., et al. (1996). Isolation and characterization of osteoblast precursor cells from human bone marrow. J. Bone Miner. Res. 11, 312-324.
37. Rosada, C., Justesen, J., Melsvik, D., et al. (2003). The human umbilical cord blood: a potential source for osteoblast progenitor cells. Calcif. Tissue Int. 72, 135-142.
38. Sanchez-Ramos, J., Song, S., Cardozo-Pelaez, F., et al. (2000). Adult bone marrow stromal cells differentiate into neural cells in vitro. Exp. Neurol. 164, 247-256.
39. Serakinci, N., Guldberg, P., Burns, J.S., et al. (2004). Adult human mesenchymal stem cell as a target for neoplastic transformation. Oncogene 23, 5095-5098.
40. Simonsen, J.L., Rosada, C., Serakinci, N., et al. (2002). Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells. Nat. Biotechnol. 20, 592-596.
41. Stenderup, K., Justesen, J., Clausen, C., et al. (2003). Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone 33, 919-926.
42. Stenderup, K., Rosada, C., Justesen, J., et al. (2004). Aged human bone marrow stromal cells maintaining bone forming capacity in vivo evaluated using an improved method of visualization. Biogerontology 5, 107-118.
43. Stock, U.A., Vacanti, J.P. (2001). Tissue engineering: current state and prospects. Annu. Rev. Med. 52, 443-451.
44. Tateishi-Yuyama, E., Matsubara, H., Murohara, T., et al. (2002). Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 360, 427-435.
45. Wollert, K.C., Meyer, G.P., Lotz, J., et al. (2004). Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364, 141-148.
46. Zhao, L.R., Duan, W.M., Reyes, M., et al. (2002). Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischemic brain of rats. Exp. Neurol. 174, 11-20.
47. Zimmermann, S., Voss, M., Kaiser, S., et al. (2003). Lack of telomerase activity in human mesenchymal stem cells. Leukemia 17, 1146-1149.